New Leaf Venture Associates Iii, L.p. - Net Worth and Insider Trading

New Leaf Venture Associates Iii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, New Leaf Venture Associates Iii, L.p. owns 6 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Harpoon Therapeutics Inc (HARP) , and Arvinas Inc (ARVN) among others .

Click here to see the complete history of New Leaf Venture Associates Iii, L.p.’s form 4 insider trades.

Insider Ownership Summary of New Leaf Venture Associates Iii, L.p.

Ticker Comapny Transaction Date Type of Owner
DCPH Deciphera Pharmaceuticals Inc 2017-09-27 10 percent owner
HARP Harpoon Therapeutics Inc 2021-01-11 10 percent owner
ARVN Arvinas Inc 2018-09-26 10 percent owner
LIMIT LIMIT 2018-06-20 10 percent owner
LIMIT LIMIT 2018-05-24 10 percent owner
LIMIT LIMIT 2016-06-21 director

New Leaf Venture Associates Iii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

New Leaf Venture Associates Iii, L.p. Ownership Network

Ownership Network List of New Leaf Venture Associates Iii, L.p.

No Data

Ownership Network Relation of New Leaf Venture Associates Iii, L.p.

Insider Network Chart

New Leaf Venture Associates Iii, L.p. Owned Company Details

What does Deciphera Pharmaceuticals Inc do?

Who are the key executives at Deciphera Pharmaceuticals Inc?

New Leaf Venture Associates Iii, L.p. is the 10 percent owner of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and Chief Commercial Officer Daniel C. Martin .

Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary

Over the past 18 months, New Leaf Venture Associates Iii, L.p. made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 23,797 shares made by Daniel C. Martin , a net sale of 12,184 shares made by Matthew L Sherman , and a net sale of 9,198 shares made by Thomas Patrick Kelly .

In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 105,002 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 95,002 shares.

Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Deciphera Pharmaceuticals Inc Insider Transactions

No Available Data

New Leaf Venture Associates Iii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for New Leaf Venture Associates Iii, L.p.. You might contact New Leaf Venture Associates Iii, L.p. via mailing address: C/o New Leaf Venture Partners, 7 Times Square, Suite 3502, New York Ny 10036.